Etiopathological factors of hepatocellular carcinoma in Bangui, Central African Republic: Clinical, biological characteristics and virological aspects of patients;Étiopathologie du carcinome hépatocellulaire à Bangui, République centrafricaine: Caractéristiques cliniques, biologiques et aspects virologiques des patients

Pathologie Biologie

Volumn 58, Issue 2, 2010, Pages 152-155

  Bekondi, C ^a   Mobima, T ^b   Ouavene J O ^b   Koffi, B ^c   Konamna, X ^a   Bere A ^a   Le Faou, A ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b Hopital de l'Amitie   (Central African Republic)

^c Service d'anatomie et de cytologie pathologique   (Central African Republic)

Author keywords

Central African Republic; Fine needle aspiration; HBV; HDV; Hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; PROTHROMBIN; TUMOR MARKER; VIRUS ANTIBODY; VIRUS ANTIGEN;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPIRATION BIOPSY; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CACHEXIA; CANCER STAGING; CENTRAL AFRICAN REPUBLIC; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; ADOLESCENT; BLOOD; COMORBIDITY; DELTA AGENT HEPATITIS; HEPATITIS B; HEPATITIS C; HYPERBILIRUBINEMIA; LIVER TUMOR; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; SOCIOECONOMICS; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ASPARTATE AMINOTRANSFERASES; BIOPSY, FINE-NEEDLE; CARCINOMA, HEPATOCELLULAR; CENTRAL AFRICAN REPUBLIC; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS D; HUMANS; HYPERBILIRUBINEMIA; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTHROMBIN; SOCIOECONOMIC FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 77952098491     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2009.07.027     Document Type: Article

References (15)

1. Buendia M.A. Genetics of hepatocellular carcinoma. Semin Cancer Biol 2000, 10:185-200.
2. Saffroy R., Pham P., Lemoine A., Debuire B. Biologie moléculaire et carcinome hépatocellulaire: données actuelles et développements futurs. Ann Biol Clin 2004, 62:649-656.
3. Cupta S., Bent S., Hohlwes J. Test characteristics of α-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. Ann Intern Med 2003, 139:46-50.
4. Szmuness W. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols. J Med Virol 1979, 4:327-340.
5. Kurbanov F., Tanaka Y., Fujiwara K., Sugauchi F., Mbanya D., Zekeng L., et al. A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol 2005, 86:2047-2056.
6. Makuwa M., Souquiere S., Telfer P., Apetrei C., Vray M., Bedjabaga I., et al. Identification of hepatitis B virus subgenotype A3 in rural Gabon. J Med Virol 2006, 78:1175-1184.
7. Beasley R.P., Lin C.C., Hwang L.Y., Chien C.S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 1981, II:1129-1133.
8. Ross R.K., Yuan J.M., Yu M.C., Wogan G.N., Qian G.S., Tu J.T., et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992, 339:943-946.
9. Chen C.J., Wang L.Y., Lu S.N., Wu M.H., You S.L., Zhang Y.J., et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996, 24:38-42.
10. Chen C.J., Yu M.W., Liaw Y.F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997, 12(9-10):S294-308.
11. Meunier D.M., Vohito M.D., Courrouce A.M., Lesbordes J.L., Georges-Courbot M.C., Georges A.J. Prevalence of hepatitis B surface antigen and determination of its subtypes in the Central African Republic. Bull Soc Pathol Exot Filiales 1984, 77(3):249-254.
12. Pawlotsky J.M., Belec L., Gresenguet G., Deforges L., Bouvier M., Duval J., et al. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 1995, 46:269-272.
13. Mammette A. Virologie médicale. Collection AZAY. Presses universitaires de Lyon; 2002. p. 545-68.
14. World Health Organization. Report of the fourteenth meeting of the Global Advisory Group of the Expanded Programme on Immunization. Wkly Epidemiol Rec 992;3:11-5.
15. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995, 13(S1):547-549.